Tomasz Milewicz

965 total citations
85 papers, 728 citations indexed

About

Tomasz Milewicz is a scholar working on Endocrinology, Diabetes and Metabolism, Reproductive Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Tomasz Milewicz has authored 85 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 19 papers in Reproductive Medicine and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Tomasz Milewicz's work include Ovarian function and disorders (16 papers), Growth Hormone and Insulin-like Growth Factors (13 papers) and Estrogen and related hormone effects (8 papers). Tomasz Milewicz is often cited by papers focused on Ovarian function and disorders (16 papers), Growth Hormone and Insulin-like Growth Factors (13 papers) and Estrogen and related hormone effects (8 papers). Tomasz Milewicz collaborates with scholars based in Poland, United States and France. Tomasz Milewicz's co-authors include Ewa Ł. Gregoraszczuk, Anna K. Wójtowicz, Krystyna Sztefko, Agnieszka Rak, Adam Grochowalski, Maria Kapiszewska, Sandra Mrozińska, Erik Taubøll, Robert Jach and Ryszard Chrząszcz and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and International Journal of Molecular Sciences.

In The Last Decade

Tomasz Milewicz

78 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomasz Milewicz Poland 17 162 138 126 110 100 85 728
Winifred P.S. Wong United States 10 228 1.4× 56 0.4× 75 0.6× 70 0.6× 78 0.8× 13 777
Manjunatha K. Nanjappa United States 11 181 1.1× 201 1.5× 182 1.4× 29 0.3× 88 0.9× 17 775
Jiexue Pan China 19 210 1.3× 531 3.8× 143 1.1× 69 0.6× 340 3.4× 48 1.1k
Nataša Nestorović Serbia 17 124 0.8× 107 0.8× 55 0.4× 25 0.2× 58 0.6× 77 799
Szabolcs Várbı́ró Hungary 18 107 0.7× 288 2.1× 33 0.3× 105 1.0× 241 2.4× 112 1.2k
De‐Xiang Xu China 14 148 0.9× 71 0.5× 160 1.3× 68 0.6× 90 0.9× 22 697
Eftychia Koukkou Greece 20 192 1.2× 160 1.2× 66 0.5× 276 2.5× 133 1.3× 72 1.2k
Anna Tropea Italy 18 54 0.3× 482 3.5× 63 0.5× 171 1.6× 243 2.4× 40 824
Patrycja Kurowska Poland 17 85 0.5× 169 1.2× 24 0.2× 48 0.4× 104 1.0× 44 712
Sebahat Turgut Türkiye 21 178 1.1× 41 0.3× 177 1.4× 18 0.2× 43 0.4× 79 1.1k

Countries citing papers authored by Tomasz Milewicz

Since Specialization
Citations

This map shows the geographic impact of Tomasz Milewicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Milewicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Milewicz more than expected).

Fields of papers citing papers by Tomasz Milewicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomasz Milewicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Milewicz. The network helps show where Tomasz Milewicz may publish in the future.

Co-authorship network of co-authors of Tomasz Milewicz

This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Milewicz. A scholar is included among the top collaborators of Tomasz Milewicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Milewicz. Tomasz Milewicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Opydo‐Chanek, Małgorzata, et al.. (2024). Visfatin exerts an anti-proliferative and pro-apoptotic effect in the human placenta cells. Biology of Reproduction. 112(2). 375–391.
2.
Zapała, Barbara, et al.. (2024). Reduction in the Free Androgen Index in Overweight Women After Sixty Days of a Low Glycemic Diet. Experimental and Clinical Endocrinology & Diabetes. 132(1). 6–14. 1 indexed citations
3.
Gawlik, Katarzyna, Tomasz Milewicz, Dorota Pawlica-Gosiewska, Iwona Trznadel-Morawska, & Bogdan Solnica. (2023). Fibroblast Growth Factor 21 in Gestational Diabetes Mellitus and Type 2 Diabetes Mellitus. Journal of Diabetes Research. 2023. 1–6. 4 indexed citations
4.
Mlyczyńska, Ewa, et al.. (2021). Apelin, APJ, and ELABELA: Role in Placental Function, Pregnancy, and Foetal Development—An Overview. Cells. 11(1). 99–99. 30 indexed citations
5.
Mlyczyńska, Ewa, et al.. (2021). Anti-Apoptotic Effect of Apelin in Human Placenta: Studies on BeWo Cells and Villous Explants from Third-Trimester Human Pregnancy. International Journal of Molecular Sciences. 22(5). 2760–2760. 16 indexed citations
6.
Mrozińska, Sandra, et al.. (2018). The PCOS Patients differ in Lipid Profile According to their Phenotypes. Experimental and Clinical Endocrinology & Diabetes. 126(7). 437–444. 17 indexed citations
7.
8.
Milewicz, Tomasz, et al.. (2017). Pressure pain threshold and β-endorphins plasma level are higher in lean polycystic ovary syndrome women. Minerva Endocrinology. 42(4). 297–305. 8 indexed citations
9.
Zagrodzki, Paweł, et al.. (2017). Selenium status parameters in patients with polycystic ovary syndrome. Journal of Trace Elements in Medicine and Biology. 44. 241–246. 15 indexed citations
10.
Milewicz, Tomasz, et al.. (2016). Basic and Meal Stimulated Plasma GIP Levels are Higher in Lean PCOS Women with FAI over 5. Experimental and Clinical Endocrinology & Diabetes. 124(2). 77–81. 4 indexed citations
11.
Milewicz, Tomasz, et al.. (2015). [Changes in blood pressure and heart rate by an increase in serum estradiol in women undergoing controlled ovarian hyperstimulation].. PubMed. 72(4). 174–7. 3 indexed citations
12.
Milewicz, Tomasz, et al.. (2013). Markers of insulin resistance in perimenopausal women with endometrial pathology. Ginekologia Polska. 84(11). 922–9. 16 indexed citations
13.
Milewicz, Tomasz, et al.. (2013). [Metformin--new treatment strategies for gynecologic neoplasms].. PubMed. 70(2). 81–4. 4 indexed citations
14.
Milewicz, Tomasz, Janusz Ryś, Anna K. Wójtowicz, et al.. (2011). Overexpression of P53 protein and local hGH, IGF-I, IGFBP-3, IGFBP-2 and PRL secretion by human breast cancer explants.. PubMed. 32(3). 328–33. 7 indexed citations
15.
Milewicz, Tomasz, et al.. (2006). 17beta-estradiol regulation of human growth hormone (hGH), insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) axis in hypoestrogenic, hypergonadotropic women.. PubMed. 56(6). 876–82. 2 indexed citations
16.
Malewski, Tadeusz, et al.. (2005). Regulation of Msx2 Gene Expression by Steroid Hormones in Human Nonmalignant and Malignant Breast Cancer Explants Cultured in Vitro. Cancer Investigation. 23(3). 222–228. 12 indexed citations
17.
Sztefko, Krystyna, et al.. (2005). Effect of hormone therapy on the enteroinsular axis. Menopause The Journal of The North American Menopause Society. 12(5). 630–638. 11 indexed citations
18.
19.
Milewicz, Tomasz, Krystyna Sztefko, Janusz Ryś, et al.. (2003). The impact of progesterone on simultaneous, local secretion of IGFBP-3 and IGF-I [IGFBP-3/IGF-I index] by human malignant and non-malignant breast explants depends on tissue steroid receptor phenotype.. PubMed. 74(9). 767–74. 4 indexed citations
20.
Gregoraszczuk, Ewa Ł., et al.. (2001). Progesterone-induced secretion of growth hormone ,insulin-like growth factor I and prolactin by human breast cancer explants. Gynecological Endocrinology. 15(4). 251–258. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Winifred P.S. Wong Breakdown of academic impact, for papers by Manjunatha K. Nanjappa Breakdown of academic impact, for papers by Jiexue Pan Breakdown of academic impact, for papers by Nataša Nestorović Breakdown of academic impact, for papers by Szabolcs Várbı́ró Breakdown of academic impact, for papers by De‐Xiang Xu Breakdown of academic impact, for papers by Eftychia Koukkou Breakdown of academic impact, for papers by Anna Tropea Breakdown of academic impact, for papers by Patrycja Kurowska Breakdown of academic impact, for papers by Sebahat Turgut
Rankless by CCL
2026